We are honored and excited to participate and contribute to the new KG Jebsen Center for Myeloid Blood Cancer.
The main goal is to develop diagnostics at the single-cell level that reveal response to treatment after hours and days, and use this information to optimize or replace the planned treatment. The Center is supported by generous funds from the Stiftelsen Kristian Gerhard Jebsen, the University of Bergen, Helse Bergen, the Blood Cancer Society and the Norwegian Cancer Society.
The Kristian Gerhard Jebsen Foundation grants 21 million for a major investment in cancer research. The University of Bergen is following up with significant funding for research at the centre. The center therefore has a budget of 43 million in total over the next five years.
More press about the Center and an interview with professor and senior physician Bjørn Tore Gjertsen, the research center leader, you can read here:
- Satser storstilt på bedre behandling av blodkreft (in Norwegian) – UiB News or Stiftelsen Kristian Gerhard Jebsen